Amphastar Pharmaceuticals Inc Earnings

Amphastar Pharmaceuticals Inc’s revenue jumped 1.6% since last year same period to $191.84Mn in the Q3 2025. On a quarterly growth basis, Amphastar Pharmaceuticals Inc has generated 9.99% jump in its revenue since last 3-months.

Amphastar Pharmaceuticals Inc’s net profit fell -57.09% since last year same period to $17.35Mn in the Q3 2025. On a quarterly growth basis, Amphastar Pharmaceuticals Inc has generated -44.09% fall in its net profits since last 3-months.

Amphastar Pharmaceuticals Inc’s net profit margin fell -57.76% since last year same period to 9.04% in the Q3 2025. On a quarterly growth basis, Amphastar Pharmaceuticals Inc has generated -49.17% fall in its net profit margins since last 3-months.

Amphastar Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at 0.79 - a -14.12% fall from last quarter’s estimates.

Amphastar Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at 0.79.

Amphastar Pharmaceuticals Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Amphastar Pharmaceuticals Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.